Lataa...

Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2020-10-01
Sarja:Cancers
Aiheet:
Linkit:https://www.mdpi.com/2072-6694/12/10/2993
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!